49th week of 2019 patent applcation highlights part 10 |
Patent application number | Title | Published |
20190365619 | ANTI-DANDRUFF CLEANSING COMPOSITION | 2019-12-05 |
20190365620 | COSMETIC COMPOSITION | 2019-12-05 |
20190365621 | Oral Care Compositions | 2019-12-05 |
20190365622 | CONCENTRATED RINSE-OFF CLEANSING COMPOSITION | 2019-12-05 |
20190365623 | NON-SULFATE CONCENTRATED RINSE-OFF CLEANSING COMPOSITION | 2019-12-05 |
20190365624 | Aqueous Surfactant Compositions | 2019-12-05 |
20190365625 | HAIR COLOR-ALTERING COMPOSITIONS | 2019-12-05 |
20190365626 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | 2019-12-05 |
20190365627 | SKIN TREATMENT COMPOSITIONS, MASKS, AND RELATED METHODS | 2019-12-05 |
20190365628 | COMPOSITION IN THE FORM OF NANO- OR MICRO- EMULSION | 2019-12-05 |
20190365629 | TOPICAL COMPOSITIONS AND METHODS | 2019-12-05 |
20190365630 | ANTIBACTERIAL PARTICLES AND METHODS | 2019-12-05 |
20190365631 | NAIL ENAMEL COMPOSITION | 2019-12-05 |
20190365632 | SILICONE RESIN, MAKING METHOD, AND COSMETICS | 2019-12-05 |
20190365633 | METHOD OF TREATING HAIR WITH A CONCENTRATED CONDITIONER | 2019-12-05 |
20190365634 | Human Axilla Cleansing Compound | 2019-12-05 |
20190365635 | Facial Hydrating Oil | 2019-12-05 |
20190365636 | Natural and Organic Deodorant | 2019-12-05 |
20190365637 | CYTOMIMETIC FORMULATIONS AND METHODS OF MANUFACTURING THE SAME | 2019-12-05 |
20190365638 | METHOD FOR PRODUCING COSMETIC COMPOSITION USING SKIN SERUM | 2019-12-05 |
20190365639 | METHOD FOR PRODUCING ORAL COMPOSITION, AND ORAL COMPOSITION | 2019-12-05 |
20190365640 | LACTOBACILUS REUTERI CH53 STRAIN HAVING HIGH PRODUCTIVITY OF 1,3-PROPANEDIOL FROM GLYCEROL AND USES THEREOF | 2019-12-05 |
20190365641 | RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS OF USE | 2019-12-05 |
20190365642 | Method and Formulation for Improving Roflumilast Skin Penetration Lag Time | 2019-12-05 |
20190365643 | INJECTABLE COMPOSITION WITH AROMATASE INHIBITOR | 2019-12-05 |
20190365644 | DRUG DELIVERY SYSTEM | 2019-12-05 |
20190365645 | DRUG DELIVERY ARTICLES FOR GRAM-LEVEL DOSING | 2019-12-05 |
20190365646 | EXPANDABLE GASTRORETENTIVE DOSAGE FORM | 2019-12-05 |
20190365647 | PROCESS FOR PRODUCING A NANO-CBD MICROEMULSION SYSTEM | 2019-12-05 |
20190365648 | SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES | 2019-12-05 |
20190365649 | COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED THIAZOLIDINEDIONES AND LIPOSOME-ENCAPSULATED VASODILATORS, AND THEIR USE TO AMELIORATE ATHEROMA | 2019-12-05 |
20190365650 | TARGETED POLYMERIZED NANOPARTICLES FOR CANCER TREATMENT | 2019-12-05 |
20190365651 | SUSTAINED RELEASE PARTICLE FORMULATIONS | 2019-12-05 |
20190365652 | POLY(KETALS) AND RELATED COMPOSITIONS AND METHODS | 2019-12-05 |
20190365653 | NOVEL RECOMBINANT EXOSOME CONTAINING HYALURONIDASE AND USE THEREOF | 2019-12-05 |
20190365654 | APPARATUS AND PROCESS FOR ENCAPSULATING CAPSULES OR OTHER SOLID DOSAGE FORMS WITHIN CAPSULES | 2019-12-05 |
20190365655 | TASTE MASKING DRUG FORMULATIONS | 2019-12-05 |
20190365656 | PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES | 2019-12-05 |
20190365657 | TUMOR-TARGETING BEAD VECTORS AND METHODS OF USING THE SAME | 2019-12-05 |
20190365658 | COATED EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS AND METHODS FOR USING THE SAME | 2019-12-05 |
20190365659 | DRUG CARRIER HAVING SELF-ASSEMBLED 3-D NUCLEIC ACID NANOSTRUCTURE | 2019-12-05 |
20190365660 | NANOCAPSULES AND METHOD FOR MANUFACTURING THEREOF | 2019-12-05 |
20190365661 | SUBLINGUAL FILMS | 2019-12-05 |
20190365662 | CONTROLLING WATER RELEASE FROM A DIMENSIONALLY STABLE AQUEOUS COMPOSITION | 2019-12-05 |
20190365663 | METHOD FOR MAKING A TRANSDERMAL FENTANYL PATCH WITH EVEN DRUG CRYSTAL DISTRIBUTION | 2019-12-05 |
20190365664 | CARYOPHYLLENE FORMULATIONS, APPARATUSES, AND METHODS | 2019-12-05 |
20190365665 | ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF | 2019-12-05 |
20190365666 | METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN | 2019-12-05 |
20190365667 | ORAL CANNABINOID FORMULATIONS | 2019-12-05 |
20190365668 | METHOD FOR TREATING DEVELOPMENTAL RETINAL VASCULAR DISORDER | 2019-12-05 |
20190365669 | HYDROGEN SULFIDE AND/OR NITRITE IN THE TREATMENT AND PREVENTION OF ATRIAL FIBRILLATION | 2019-12-05 |
20190365670 | METHOD FOR PRODUCING A SEA URCHIN EXTRACT ENRICHED WITH 1,4-POLYHYDROXYLATED NAPHTHOQUINONES WITH ANTIMICROBIAL AND ANTIOXIDANT ACTIVITY | 2019-12-05 |
20190365671 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS | 2019-12-05 |
20190365672 | Transmucosal Ketamine Delivery Composition | 2019-12-05 |
20190365673 | Immunomodulatory Compounds | 2019-12-05 |
20190365674 | USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME | 2019-12-05 |
20190365675 | COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF ALCOHOL USE DISORDERS | 2019-12-05 |
20190365676 | ORAL COMPOSITOINS AND METHODS OF USE | 2019-12-05 |
20190365677 | AGENTS THAT INHIBIT NGLY1 AND METHODS OF USE THEREOF | 2019-12-05 |
20190365678 | Method for Treating Pain | 2019-12-05 |
20190365679 | COMPOSITIONS AND METHODS FOR REGULATING BODY WEIGHT AND METABOLIC SYNDROMES | 2019-12-05 |
20190365680 | USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATED LIVER CANCER | 2019-12-05 |
20190365681 | TREATMENT OF CANCER WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2019-12-05 |
20190365682 | TOPICAL ANTI-INFLAMMATORY COMPOSITIONS | 2019-12-05 |
20190365683 | PHARMACEUTICAL COMPOSITIONS AND THE TREATMENT OF OVERACTIVE BLADDER | 2019-12-05 |
20190365684 | INHIBITORS OF PLASMINOGEN FOR TREATING, REDUCING OR PREVENTING RADIATION-INDUCED INJURIES | 2019-12-05 |
20190365685 | EYE DROPS FOR TREATING DRY EYE | 2019-12-05 |
20190365686 | EYE DROPS FOR TREATING DRY EYE | 2019-12-05 |
20190365687 | PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE | 2019-12-05 |
20190365688 | AMIDE DERIVATIVE | 2019-12-05 |
20190365689 | USE OF APE/REF-1 REDOX SPECIFIC INHIBITORS FOR TREATING METASTATIC PROSTATE CANCER | 2019-12-05 |
20190365690 | Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments | 2019-12-05 |
20190365691 | HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS | 2019-12-05 |
20190365692 | OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES | 2019-12-05 |
20190365693 | INDUCTION OF ARTERIOGENESIS | 2019-12-05 |
20190365694 | COMPOSITION OF MATTER AND USE THEREOF FOR PREVENTING AND TREATING MOTION SICKNESS | 2019-12-05 |
20190365695 | ANAPLEROTIC THERAPY OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES | 2019-12-05 |
20190365696 | METHOD FOR TREATING BENIGN PROSTATIC HYPERPLASIA (BPH), PROSTATITIS, AND PROSTATE CANCER | 2019-12-05 |
20190365697 | Method for Treating Liver Dysfunction | 2019-12-05 |
20190365698 | Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer | 2019-12-05 |
20190365699 | Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles | 2019-12-05 |
20190365700 | Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer Vaccines | 2019-12-05 |
20190365701 | Arginase Inhibitors and Their Therapeutic Applications | 2019-12-05 |
20190365702 | COMPOSITIONS COMPRISING A CANNABINOID AND SPILANTHOL | 2019-12-05 |
20190365703 | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | 2019-12-05 |
20190365704 | SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES | 2019-12-05 |
20190365705 | TOPICAL TOCOTRIENOL COMPOSITIONS AND METHODS OF INCREASING SKIN STEM CELLS | 2019-12-05 |
20190365706 | DOSING REGIMENS OF PKC ACTIVATORS | 2019-12-05 |
20190365707 | METHODS OF AMELIORATING POST-DIALYSIS WASHOUT AND NUTRITIONAL SUPPLEMENTS FOR USE IN SUCH METHODS | 2019-12-05 |
20190365708 | V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL | 2019-12-05 |
20190365709 | Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy | 2019-12-05 |
20190365710 | METHODS OF TREATING CANCER | 2019-12-05 |
20190365711 | COMPOUND HAVING ANTI-CANCER EFFECT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 2019-12-05 |
20190365712 | CRYSTALLINE FORM OF LORLATINIB FREE BASE | 2019-12-05 |
20190365713 | STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES | 2019-12-05 |
20190365714 | COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS | 2019-12-05 |
20190365715 | USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION | 2019-12-05 |
20190365716 | METHOD FOR TREATING NEURODEGENERATIVE DISEASES | 2019-12-05 |
20190365717 | TREATING PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPA-CD47 INTERACTION | 2019-12-05 |
20190365718 | COMPOUNDS USEFUL AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN DIOXYGENASE | 2019-12-05 |